Abstract Article


Development of self microemulsifying drug delivery system for simvastatin using essential oil as a carrier

Reena Shende , Satyawan Dangi , Adarsh Tiwari , Amit Dubey ,

ONLINE ISSN : 2456-8244



The present investigation was undertaken with an objective to prepare the SMEDDS of simvastatin in order to improve its bioavailability. Among the tested oils, simvastatin exhibited significantly higher solubility in lemon oil compared to all other oils. Emulsification studies showed that Span 60 was able to produce clear microemulsion with lemon oil upon dilution, and hence, it was employed as the surfactant in further studies. PEG 400 was used as the cosurfactant for the formulation of SMEDDS. The results revealed that span 60 and PEG 400 used in ratios of 2:1 (F15-16) and 3:1 (F23-24) exhibited largest microemulsion area and shortest emulsification time (less than 1 min). A fixed simvastatin concentration of 5% w/w was selected to be loaded in all selfemulsifying formulations. The in vitro dissolution studies revealed the drug release profiles for the L-SMEDDS. All the formulations exhibited quick drug release characteristics and almost complete drug release in 15-20 minutes.


Simvastatin, Essential Oil, SMEDDS, Ternary phase, Surfactant, Solubility



Global Health Observatory data. World health Organization Updates. WHO updates, 2015. Available at http://www.who.int/gho/ ncd/risk_factors/cholesterol_text/en/. [Last accessed on 22nd June 2021] Center of Disease Control and Prevention. National Center for Health Statistics. United States, 2014. Available at http:// www.cdc.gov/nchs/fastats/cholesterol.htm [Last accessed on 22nd June 2021] World Health Organization- Non communicable Diseases (NCD) Country Profiles, 2014 Global Health Observatory data. World health Organization Updates. WHO updates, 2015. Available at http://www.who.int/chp/ chronic_disease_report/en/ [Last accessed on 22nd June 2021] Joshi SR, Anjana RM, Deepa M, Pradeepa R, Bhansali A. Prevalence of Dyslipidemia in Urban and Rural India: The ICMR– INDIAB Study. PLoS ONE 9(5): e96808, 2014 doi:10.1371/journal.pone.0096808 Grundy SM. Pathogenesis of hyperlipoproteinemia. Journal of Lipid Research 1984; 25: 1611-1618. Mckenney JM. Pharmacologic Characteristics of Statins. Clinical Cardiology, 2003; 26(3): III-32–III-38. Srinivasa Rao K, Prasad T, Mohanta GP, Manna PK. An Overview of Statins as Hypolipidemic Drugs. International Journal of Pharmaceutical Sciences and Drug Research 2011; 3 (3): 178-183 Date AA, Nagarsenker M.. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. International Journal of Pharmaceutics 2007; 329:166-72. Khoo S-M, Humberstone AJ, Porter CJH, Edwards GA, Charman WN. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. International Journal of Pharmaceutics 1998; 167:155-64.